Beauty and the beast: Psychobiologic and evolutionary perspectives on body dysmorphic disorder

CNS Spectrums

Volumn 11, Issue 6, 2006, Pages 419-422

  Stein, Dan J ^a,b   Carey, Paul D ^c   Warwick, James ^c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; PSYCHEDELIC AGENT; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ADULT; AFFECT; ARTICLE; BEHAVIOR THERAPY; BODY DYSMORPHIC DISORDER; BODY IMAGE; BRAIN ATROPHY; CASE REPORT; CLINICAL TRIAL; COGNITION; COGNITIVE THERAPY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ENVIRONMENTAL FACTOR; EVOLUTION; HUMAN; INTERVIEW; MALE; META ANALYSIS; PATIENT REFERRAL; PHYSICAL ATTRACTIVENESS; PLASTIC SURGERY; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHIATRIST; PSYCHOBIOLOGY; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; SELF CONCEPT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SOMATOFORM DISORDER; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 33745317592     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900014590     Document Type: Article

References (48)

1. McGlynn SM, Schachter DL. Unawareness of deficits in neuropsychological syndromes. J Clin Exp Neuropsychol. 1989;11:143-205.
2. Maravita A, Spence C, Driver J. Multisensory integration and the body schema: Close to hand and within reach. Curr Biol. 2003;13:531-539.
3. Downing PE, Jiang Y, Shuman M, Kanwisher D. A cortical area selective for visual processing of the human body. Science. 2001;293:2470-2473.
4. Uher R, Murphy T, Friederich HC, et al. Functional neuroanatomy of body shape perception in healthy and eating-disordered women. Biol Psychiatry. 2005;58:990-997.
5. Loffler G, Yourganov G, Wilkinson F, Wilson HR. fMRI evidence for the neural representation of faces. Nat Neurosci. 2005;8:1386-1390.
6. Grill-Spector K, Knouf N, Kanwisher N. The fusiform face area subserves face perception, not generic within-category identification. Nat Neurosci. 2004;7:555-562.
7. Aharon I, Etcoff N, Ariely D, Chabris CF, O'Connor E, Breiter HC. Beautiful faces have variable reward value: fMRI and behavioral evidence. Neuron. 2001;32:537-551.
8. O'Doherty J, Winston J, Critchley H, Perrett D, Burt DM, Dolan RJ. Beauty in a smile: the role of medial orbitofrontal cortex in facial attractiveness. Neuropsychologia. 2003;41:147-155.
9. Jacobsen T, Schubotz RI, Hofel L, Cramon DY. Brain correlates of aesthetic judgment of beauty. Neuroimage. 2006;29:276-285.
10. Senior C. Beauty in the brain of the beholder. Neuron. 2003;38:525-528.
11. Rauch SL, Phillips KA, Segal E, et al. A preliminary morphometric magnetic resonance imaging study of regional brain volumes in body dysmorphic disorder. Psychiatry Res. 2003;122:13-19.
12. Carey P, Seedat S, Warwick J, van Heerden B, Stein DJ. SPECT imaging of body dysmorphic disorder. J Neuropsychiatry Clin Neurosci. 2004;16:357-359.
13. Deckersbach T, Savage CR, Phillips KA, et al. Characteristics of memory dysfunction in body dysmorphic disorder. J Int Neuropsychol Soc. 2000;6:673-681.
14. Gabbay V, Asnis GM, Bello JA, Alonso CM, Serras SJ, O'Dowd MA. New onset of body dysmorphic disorder following frontotemporal lesion. Neurology. 2003;61:123-125.
15. Hollander E, Allen A, Kwon J, et al. Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. Arch Gen Psychiatry. 1999;56:1033-1039.
16. Phillips KA, McElroy SL, Dwight MM, Eisen JL, Rasmussen SA. Delusionality and response to open-label fluvoxamine in body dysmorphic disorder. J Clin Psychiatry. 2001;62:87-91.
17. Phillips KA. Olanzapine augmentation of fluoxetine in body dysmorphic disorder. Am J Psychiatry. 2005;162:1022-1023.
18. Veale D, Gournay K, Dryden W, Boocock A, Shah F, Willson R, Walburn J. Body dysmorphic disorder: a cognitive behavioural model and pilot randomised controlled trial. Behav Hes Ther. 1996;34:717-729.
19. Greer JM, Capecchi MR. Hoxb8 is required for normal grooming behavior in mice. Neuron. 2002;33:23-34.
20. Phillips KA, Menard W, Fay C, Weisberg R. Demographic characteristics, phenomenology, comorbidity, and family history in 200 individuals with body dysmorphic disorder. Psychosomatics. 2005;46:317-325.
21. Bienvenu OJ, Samuels JF, Riddle MA, et al. The relationship of obsessive-compulsive disorder to possible spectrum disorders: results from a family study. Biol Psychiatry. 2000;48:287-293.
22. Roberts SC, Little AC, Gosling LM, et al. MHC-heterozygosity and human facial attractiveness. Evol Hum Behav. 2005;26:213-216.
23. Stein DJ, Frenkel M, Hollander E. Classification of Koro. Am J Psychiatry. 1991;148:1279-1280.
24. Hitzeroth V, Wessels C, Zungu-Dirwayi N, Oosthuizen P, Stein DJ. Muscle dysmorphia: a South African sample. Psychiatry Clin Neurosci. 2001;55:521-523.
25. Rhodes G, Yoshikawa S, Clark A, Lee K, McKay R, Akamatsu S. Attractiveness of facial averageness and symmetry in non-western cultures: in search of biologically based standards of beauty. Perception. 2001;30:611-625.
26. Rhodes G. The evolutionary psychology of facial beauty. Annu Rev Psychol. 2006;57:199-226.
27. Etcoff N. Survival of the Prettiest: The Science of Beauty. New York, NY: Anchor/Doubleday; 1999.
28. Zaidel DW, Aarde SM, Baig K. Appearance of symmetry, beauty, and health in human faces. Brain Cogn. 2005;57:261-263.
29. Cellerino A. Psychobiology of facial attractiveness. J Endocrinol Invest. 2003;26(3 suppl):45-48.
30. Thornhill R, Gangestad SW. Facial attractiveness. Trends Cog Sci. 1999;3:452-460.
31. Stein DJ. Translational and evolutionary models of body dysmorphic disorder. In: Maj M, Akiskal HS, Mezzich JE, Okasha A, eds. Somatoform Disorders. Chichester, England: John Wiley; 2005;226-227.
32. Veale D, Ennis M, Lambrou C. Possible association of body dysmorphic disorder with an occupation or education in art and design. Am J Psychiatry. 2002;159:1788-1790.
33. Atiullah N, Phillips KA. Fatal body dysmorphic disorder by proxy. J Clin Psychiatry. 2001;62:204-205.
34. Phillips KA. Body dsymorphic disorder: diagnostic controversies and treatment challenges. Bull Menninger Clin. 2000;64:18-35.
35. Simeon D, Hollander E, Stein DJ, Cohen L, Aronowitz B. Body dysmorphic disorder in the DSM-IV field trial for obsessive-compulsive disorder. Am J Psychiatry. 1995;152:1207-1209.
36. Stein DJ, Ono Y, Tajima O, Muller JE. The social anxiety disorder spectrum. J Clin Psychiatry. 2004;65:27-33.
37. Phillips KA, Menard W, Pagano ME, Fay C, Stout RL. Delusional versus nondelusional body dysmorphic disorder: clinical features and course of illness. J Psychiatr Res. 2006;40:95-104.
38. Zimmerman M, Mattia JI. Body dysmorphic disorder in psychiatric outpatients: recognition, prevalence, comorbidity, demographic, and clinical correlates. Compr Psychiatry. 1998;39:265-270.
39. Wilhelm S, Otto MW, Zucker BG, Pollack MH. Prevalence of body dysmorphic disorder in patients with anxiety disorders. J Anxiety Disord 1997;11:499-502.
40. Grant JE, Kim SW, Crow SJ. Prevalence and clinical features of body dysmorphic disorder in adolescent and adult psychiatric inpatients. J Clin Psychiatry. 2001;62:517-522.
41. Otto MW, Wilhelm S, Cohen LS, Harlow BL. Prevalence of body dysmorphic disorder in a community sample of women. Am J Psychiatry. 2001;58:2061-2063.
42. Dufresne RG, Phillips KA, Vittorio CC, Wilkel CS. A screening questionnaire for body dysmorphic disorder in a cosmetic dermatologic surgery practice. Dermatol Surg. 2001;27:457-462.
43. Phillips KA, Hollander E, Rasmussen SA, Aronowitz BR, DeCaria C, Goodman WK. A severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale-Brown Obsessive Compulsive Scale. Psychopharmacol Bull. 1997;33:17-22.
44. Phillips KA, Coles ME, Menard W, Yen S, Fay C, Weisberg RB. Suicidal ideation and suicide attempts in body dysmorphic disorder. J Clin Psychiatry. 2005;66:717-725.
45. Phillips KA, Taub SL. Skin picking as a symptom of body dysmorphic disorder. Psychopharmacol Bull. 1995;31:279-288.
46. Lucas P. Violence may be serious in men with body dysmorphic disorder. BMJ. 2002;324:678.
47. Williams J, Hadjistavropoulos T, Sharpe D. A meta-analysis of psychological and pharmacological treatments for Body Dysmorphic Disorder. Behav Res Ther. 2006;44:99-111.
48. Phillips KA. Placebo-controlled study of pimozide augmentation of fluoxetine in body dysmorphic disorder. Am J Psychiatry. 2005;162:377-379.